COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the co...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.11.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I wherein the variables are as defined herein. |
---|---|
AbstractList | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I wherein the variables are as defined herein. |
Author | VIRANI, ANISA NIZARALI JOSHI, PRAMOD FANNING, LEV TYLER DEWEY BINCH, HAYLEY MARIE PINDER, JOANNE CHARRIER, JEAN-DAMIEN KAY, DAVID O'DONNELL, MICHAEL CLEVELAND, THOMAS YOUNG, STEPHEN CLINTON STORCK, PIERRE-HENRI HURLEY, DENNIS JAMES KNEGTEL, RONALD MARCELLUS ALPHONSUS DURRANT, STEVEN JOHN GROTE, MATTHEW PAUL REAPER, PHILIP MICHAEL |
Author_xml | – fullname: BINCH, HAYLEY MARIE – fullname: FANNING, LEV TYLER DEWEY – fullname: HURLEY, DENNIS JAMES – fullname: JOSHI, PRAMOD – fullname: CHARRIER, JEAN-DAMIEN – fullname: DURRANT, STEVEN JOHN – fullname: KAY, DAVID – fullname: PINDER, JOANNE – fullname: GROTE, MATTHEW PAUL – fullname: VIRANI, ANISA NIZARALI – fullname: YOUNG, STEPHEN CLINTON – fullname: REAPER, PHILIP MICHAEL – fullname: CLEVELAND, THOMAS – fullname: O'DONNELL, MICHAEL – fullname: STORCK, PIERRE-HENRI – fullname: KNEGTEL, RONALD MARCELLUS ALPHONSUS |
BookMark | eNrjYmDJy89L5WTQcfb3DfAP9XMJVggNdnUL9VFwDFbw9PPwdPIM8Q8KVvB3U3AMCVLw9vRzDHblYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo5G5pYW5mbGjobGRCgBAD6-Jn0 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSES UTILES COMME INHIBITEURS DE LA KINASE ATR |
ExternalDocumentID | CA2798763A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2798763A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:52:46 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2798763A13 |
Notes | Application Number: CA20112798763 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&CC=CA&NR=2798763A1 |
ParticipantIDs | epo_espacenet_CA2798763A1 |
PublicationCentury | 2000 |
PublicationDate | 20111117 |
PublicationDateYYYYMMDD | 2011-11-17 |
PublicationDate_xml | – month: 11 year: 2011 text: 20111117 day: 17 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | VERTEX PHARMACEUTICALS INCORPORATED |
RelatedCompanies_xml | – name: VERTEX PHARMACEUTICALS INCORPORATED |
Score | 2.8305724 |
Snippet | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&locale=&CC=CA&NR=2798763A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_SJ4fr2jXZQ5E2bdnEtqMfsrfRjxT2Moer-O97Dev0RUMIIQmXD7hcfpfcBeDByFhZZmOEJSi7BnpeqgNWYILNtaJgQ1bpjTWyHxjTVH9ZjBcdWLW2MNJP6Jd0jogcVSC_13K_3vwosRz5tnL7lK-w6P3ZS0xHKVt1HwaqOLbpzkMn5ArnJreUIDJHdNL4XrMQKB3gKZo2zOC-2Y1Ryua3RPFO4XCOxNb1GXTEugfHvP14rQdH_u6-G7M71tuewyMP_XmYBk5M0tj10ldixWQWTGf2LAmjmIQesZKIIBq3YvcCiOcmfDrAbpf7KS65tR-gdgldRP7iCkhFhVZkLKNMaPqwUlk5KVWDCibtYUd6H_p_krn-p-4GTqRqtIn0Frr1x6e4Q9la5_dyVb4BtzF5Ug |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX5mQfpk8Vt7ZbsoUiXtrS6tqMfsrfRNh3sZQ5X8d_3Grbpi4YQQhIuH3C5_C65C8DDMGNCZAOEJSi7VD0XPZUVmGBzrShYly302hrZD4Zuqr_MBrMGLHe2MNJP6Jd0jogcVSC_V3K_Xv8osSz5tnLzlC-x6P3ZSQxLETt1HwaqWGPDnoZWyBXODW4qQWT06aj2vWYiUDrAEzatmcF-G9dGKevfEsU5gcMpEltVp9AoV21o8d3Ha2048rf33Zjdst7mDB556E_DNLBiksa2k06IGRMvcL2xl4RRTEKHmElEEI2bsX0OxLET7qrY7Xw_xTk39wPULqCJyL-8BLKgpVZkLKOs1PTuosfESPSGtGTSHravd6DzJ5mrf-ruoeUm_mQ-8YLXaziWatI60htoVh-f5S3K2Sq_kyv0DZLPfEU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+USEFUL+AS+INHIBITORS+OF+ATR+KINASE&rft.inventor=BINCH%2C+HAYLEY+MARIE&rft.inventor=FANNING%2C+LEV+TYLER+DEWEY&rft.inventor=HURLEY%2C+DENNIS+JAMES&rft.inventor=JOSHI%2C+PRAMOD&rft.inventor=CHARRIER%2C+JEAN-DAMIEN&rft.inventor=DURRANT%2C+STEVEN+JOHN&rft.inventor=KAY%2C+DAVID&rft.inventor=PINDER%2C+JOANNE&rft.inventor=GROTE%2C+MATTHEW+PAUL&rft.inventor=VIRANI%2C+ANISA+NIZARALI&rft.inventor=YOUNG%2C+STEPHEN+CLINTON&rft.inventor=REAPER%2C+PHILIP+MICHAEL&rft.inventor=CLEVELAND%2C+THOMAS&rft.inventor=O%27DONNELL%2C+MICHAEL&rft.inventor=STORCK%2C+PIERRE-HENRI&rft.inventor=KNEGTEL%2C+RONALD+MARCELLUS+ALPHONSUS&rft.date=2011-11-17&rft.externalDBID=A1&rft.externalDocID=CA2798763A1 |